Search Results

November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc allosteric modulation-based drug discovery and development, today announced that Janssen Pharmaceuticals, Inc The successful completion of this Phase 1 safety program will enable centers in Japan to be included

and Changes Name from ShouTi "San Francisco and Shanghai – August 1, 2022 – Structure Therapeutics Inc (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed

May 2022 "MONTREAL (CANADA) – May 17, 2022 – Inversago Pharma Inc. Vraniak served as the Chief Financial Officer of electroCore, Inc. and was a key member of the management Vraniak served as an executive in various innovative healthcare and technology companies including GE

Kenakin joined Glaxo Inc in RTP where he remained for 25 years through iterations of Glaxo Inc, GlaxoWellcome

Steven Foord Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to These included the identification of RAMPs (solving some CGRP family issues) and the GABA B, carboxylic

She oversaw an increase of the size of the Department, as well as a quintupling of its NIH funding, in Current areas of interest include Protease Activated Receptor signaling in the cardiovascular system She has received numerous awards, including the Glaxo Cardiovascular Discovery Award, the Distinguished